e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
Systemic and airway biomarkers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Bronchoalveolar lavage tryptase levels are correlated with type 2 airway inflammation in mild asthma
Jim Jia (San Francisco, United States of America), Guiquan Jia, Ashley Morando, Janet Jackman, Nirav Bhakta, John V. Fahy, Prescott G. Woodruff, Kelly Loyet, Tangsheng Yi, Joseph R. Arron
Source:
International Congress 2015 – Systemic and airway biomarkers
Session:
Systemic and airway biomarkers
Session type:
Thematic Poster Session
Number:
3883
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Jim Jia (San Francisco, United States of America), Guiquan Jia, Ashley Morando, Janet Jackman, Nirav Bhakta, John V. Fahy, Prescott G. Woodruff, Kelly Loyet, Tangsheng Yi, Joseph R. Arron. Bronchoalveolar lavage tryptase levels are correlated with type 2 airway inflammation in mild asthma. Eur Respir J 2015; 46: Suppl. 59, 3883
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
The use of bronchoalveolar lavage (BAL) to assess lower airways inflammation in asthma
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016
Periostin in lower airway samples and serum, a novel asthma marker?
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015
Are there differences in the bronchoalveolar lavage (BAL) cytokine profile in children with and without allergic asthma?
Source: International Congress 2014 – More paediatric asthma
Year: 2014
Bronchoalveolar lavage in severe persistent asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 584s
Year: 2002
Refractory severe asthma: Is presence of aspergillus in broncho-alveolar lavage significant?
Source: International Congress 2015 – Respiratory infections: from basic science to clinical issues
Year: 2015
The impact of smoking on bronchoalveolar lavage fluid (BALf) amyloid A concentration in patients with sarcoidosis
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013
Chemokine concentrations in bronchoalveolar lavage (BAL) in asthma and eosinophilic bronchitis
Source: Annual Congress 2004 - Immunology of airway and pulmonary disease
Year: 2004
The value of bronchoalveolar lavage in the diagnosis and management of small airway disease
Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis
Year: 2014
Characterization of inflammation in bronchoalveolar lavage of lung transplant patients
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013
Electronic nose breathprints reflect BALF inflammatory cell counts in asthma
Source: Annual Congress 2013 –Asthma
Year: 2013
Bronchoalveolar lavage: how can we use it more effectively to define pathology?
Source: Annual Congress 2006 - Molecular pathology: an approach to lung diseases
Year: 2006
Bronchoalveolar lavage fluid findings in children with hypersensitivity pneumonitis
Source: Eur Respir J 2003; 21: 144-148
Year: 2003
Assessment of inflammation in asthma with ECP, endobronchial biopsy, bronchoalveolar lavage and sputum eosinophilia
Source: Eur Respir J 2004; 24: Suppl. 48, 594s
Year: 2004
Cytologicalfeaturesof bronchoalveolar lavage in different variants of exogenous allergic alveolitis
Source: International Congress 2014 – ILDs 5
Year: 2014
Bronchoalveolar lavage in children with persistent asthmatic symptoms
Source: Eur Respir J 2001; 18: Suppl. 33, 295s
Year: 2001
Bronchoalveolar lavage fluid leukotrienes in the pathomechanism of acute inflammatory events in lung transplant recipients
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016
Longitudinal evaluation of airway inflammation in stable CF patients by bronchoalveolar lavage (BAL) and influence of rhDNAse
Source: Eur Respir J 2002; 20: Suppl. 38, 528s
Year: 2002
Investigation of mitochondria homeostasis and mitophagy in bronchoalveolar lavage fluid (BALF) cells in pulmonary fibrosis
Source: International Congress 2015 – IPF pathogenesis
Year: 2015
Can IL-4Ralpha and PAR-2 in bronchoalveolar lavage fluid serve as biomarker of fibroproliferative healing in interstitial lung diseases?
Source: International Congress 2015 – New insights into IIPs
Year: 2015
Lipid-laden macrophage index and inflammation in bronchoalveolar lavage fluids in children
Source: Eur Respir J 2001; 18: 790-795
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept